RSS Atom • ISSN 1472-4683 • Subscribe • About
Hepatitis coinfection
- Hepatitis C coinfection studies Conference reports - Hepatitis coinfection - CROI 19 (Retrovirus) 2012 - 1 April 2012
- FDA supplemental information about using boceprevir and telaprevir Hepatitis coinfection - 1 August 2011
- Route of HCV transmission in HIV-positive gay men is unlikely to be from semen Conference reports - Hepatitis coinfection - BHIVA/BASHH 2nd Manchester 2010 - 1 June 2010
- Hepatitis studies: IL28B genetics, HCV survival, FibroScan in acute HCV, MSM reinfection and responses to transplantation Conference reports - Hepatitis coinfection - CROI 17 (Retrovirus) 2010 - 1 June 2010
- The HCV pipeline – efficacy and side effect of compounds in Phase 3 studies Conference reports - Hepatitis coinfection - Lipodystrophy Workshop (IWADRW) 11 Philadelphia 2009 - 20 February 2010
- HBV resistance to lamivudine at undetectable and low levels of viremia Conference reports - Hepatitis coinfection - Resistance - Intl Drug Resistance Workshop 18 Florida 2009 - 22 August 2009
- HIV and hepatitis coinfection guidelines online for comment BHIVA news - Guidelines - Hepatitis coinfection - 3 June 2009
- Use of fibroscan as non-invasive alternative to liver biopsy in HCV/HIV coinfection Conference reports - Hepatitis coinfection - BHIVA 14th Belfast 2008 - 12 June 2008
- UK cohort reports sexual HCV reinfection in at least 5% HIV-positive gay men following sustained response to treatment Conference reports - Hepatitis coinfection - CROI 15 (Retrovirus) 2008 - 1 April 2008
- MELD score predictive of pre-transplant mortality in HCV coinfected patients Conference reports - Hepatitis coinfection - CROI 15 (Retrovirus) 2008 - 1 April 2008
- Does abacavir decrease SVR rates with HCV treatment? Conference reports - Hepatitis coinfection - CROI 15 (Retrovirus) 2008 - 1 April 2008
- No effect of interferon maintenance therapy on fibrosis progression in non-responders Conference reports - Hepatitis coinfection - CROI 15 (Retrovirus) 2008 - 1 April 2008
- Comparative study of pegylated interferon formulations in HCV monotherapy Hepatitis coinfection - 1 February 2008
- Risk of antibody negative HCV infection in four US HIV cohorts: risk linked to IDU, elevated ALT and low CD4 count Hepatitis coinfection - 2 October 2007
- HBV or HCV coinfection produced higher risk from treatment interruptions: drug holidays and hepatitis don’t mix Conference reports - Hepatitis coinfection - IAS 4 Sydney 2007 - 3 September 2007
- BMS issue Dear Doctor letter about risk of entecavir in HIV/HBV coinfection Hepatitis coinfection - 3 September 2007
- Low rates of HCV treatment among eligible injection drug users Conference reports - Hepatitis coinfection - CROI 14 (Retrovirus) 2007 - 3 July 2007
- Effect of HCV and HIV on mortality among injecting drug users Conference reports - Hepatitis coinfection - CROI 14 (Retrovirus) 2007 - 3 July 2007
- HCV/HIV-co-infected IDUs are at increased risk of death from hepatitis-related death in the HAART era, compared with HCV-mono-IDUs Conference reports - Hepatitis coinfection - CROI 14 (Retrovirus) 2007 - 3 July 2007
- Schering’s pegylated interferon approved for treating hepatitis C in HIV coinfected patients Hepatitis coinfection - 3 July 2007
- Sexual transmission of HCV in Brighton reported in HIV-positive and HIV-negative MSM Conference reports - Hepatitis coinfection - CROI 14 (Retrovirus) 2007 - 4 April 2007
- Hepatitis B drug entecavir reported to have anti-HIV viral activity in three patients Conference reports - Hepatitis coinfection - CROI 14 (Retrovirus) 2007 - 4 April 2007
- Increased prevalence of cardiovascular disease among HIV-positive individuals coinfected with hepatitis C Hepatitis coinfection - 5 February 2007
- Higher doses of ribavirin increases response rate to HCV treatment in coinfected patients: results from PRESCO study Conference reports - Hepatitis coinfection - HIV 8 Glasgow 2006 - 6 December 2006
- NNRTI levels high in HCV co-Infected patients with cirrhosis Conference reports - Hepatitis coinfection - HIV 8 Glasgow 2006 - 6 December 2006
- Nucleoside inhibitor MK-0608 mediates suppression of HCV replication for >30 days in chronically infected chimpanzees Conference reports - Hepatitis coinfection - ICAAC 46th San Francisco 2006 - 7 October 2006
- Efficacy of treatment of acute hepatiitis C in patients with HIV infection Hepatitis coinfection - 3 August 2006
- HIV/HCV coinfection: re-treating hepatitis C in people coinfected with HIV Hepatitis coinfection - Special reports - 13 April 2006
- Sexual transmission of hepatitis C in HIV-positive men in the UK Conference reports - Hepatitis coinfection - CROI 13 (Retrovirus) 2006 - 25 March 2006
- One third of HIV/HCV coinfected patients with normal ALT have advanced fibrosis in Spanish cohort Conference reports - Hepatitis coinfection - ICAAC 45th Washingon 2005 - 16 March 2006
- Low HIV viral load linked to hepatitis B vaccination response Hepatitis coinfection - 8 February 2006
- HPA releases HCV report without mentioning sexual transmission among HIV-positive gay men Hepatitis coinfection - 8 February 2006
- Management of hepatitis C and B in HIV-coinfected individuals: an overview of studies presented at the 3rd IAS Conference Conference reports - Hepatitis coinfection - IAS 3 Rio de Janeiro 2005 - 13 October 2005
- EMEA statement on use of antiretroviral treatment in HIV-patients with hepatic impairment and/or HBV/HCV co-infection Hepatitis coinfection - Side effects - 13 September 2005
- Sexual transmission and response to treatment in acute HCV infection in HIV-positive gay men coinfected with HIV Conference reports - Hepatitis coinfection - BHIVA 11th Dublin 2005 - 15 June 2005
- UK guidelines for liver transplant in HIV-positive patients Guidelines - Hepatitis coinfection - 15 May 2005
- Sexual HCV reinfection of HIV-positive gay man while receiving PEG-interferon plus ribavirin Hepatitis coinfection - 15 May 2005
- First European recommendations for the treatment of patients co-infected with HIV and HBV/HCV Hepatitis coinfection - 15 May 2005
- Entecavir is effective against 3TC-resistant hepatitis B Conference reports - Hepatitis coinfection - CROI 12 (Retrovirus) 2005 - 18 April 2005
- Tenofovir is non-inferior to adefovir for the treatment of hepatitis B in HBV-HIV co-infected patients Conference reports - Hepatitis coinfection - CROI 12 (Retrovirus) 2005 - 18 April 2005
- Pegasys approved for HIV/hepatitis C coinfection in Europe and US Hepatitis coinfection - 18 April 2005
- Pegasys approved in Europea for the treatment of chronic hepatitis B Hepatitis coinfection - 18 April 2005
- HCV coinfection linked to discontinuing ART due to toxicity Conference reports - Hepatitis coinfection - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005
- Updated UK guidelines for HIV and hepatitis coinfection Guidelines - Hepatitis coinfection - 29 January 2005
- BHIVA audit on management of HIV/Hepatitis coinfection Conference reports - Hepatitis coinfection - BHIVA Autumn 2004 - 6 November 2004
- BMS submits marketing applications for entecavir to treat HBV in US and Europe Hepatitis coinfection - 6 November 2004
- Responses to hepatitis vaccinations: an optimum window for protection? Conference reports - Hepatitis coinfection - World AIDS 15 Bangkok 2004 - 6 September 2004
- HBV vaccine, CD4 count and increasing response with double-dose Conference reports - Hepatitis coinfection - Opportunistic infections and complications - World AIDS 15 Bangkok 2004 - 6 September 2004
- Response to Hepatitis A (HAV) vaccine determined by CD4 count Conference reports - Hepatitis coinfection - World AIDS 15 Bangkok 2004 - 6 September 2004
- The 39th Annual Meeting of the European Association for the Study of the Liver (39th EASL) Hepatitis coinfection - 2 June 2004
- Tenofovir blocks viral replication in HBV monoinfected and in HIV-HBV coinfected patients with lamivudine resistance Hepatitis coinfection - 2 June 2004
- Compared to Caucasians, Africans have significantly higher rates of fibrosis and cirrhosis despite lower levels of HBV replication Hepatitis coinfection - 2 June 2004
- Undetectable HIV viral load in HIV-HCV coinfected patients slows liver fibrosis progression rate Hepatitis coinfection - 2 June 2004
- Ribavirin (RBV) does not alter intracellular levels of AZT, 3TC or d4T Conference reports - Hepatitis coinfection - PK and drug interactions - CROI 11 (Retrovirus) 2004 - 3 April 2004
- HIV/HCV coinfection: superiority of pegylated interferon plus ribavirin, but lower response rate compared to mono-infected patients, especially for genotype-1 Conference reports - Hepatitis coinfection - CROI 11 (Retrovirus) 2004 - 2 April 2004
- Epoetin-alfa improves interferon/ribavirin-associated anaemia Conference reports - Hepatitis coinfection - CROI 11 (Retrovirus) 2004 - 2 April 2004
- International panel issues new guidelines for the care of HIV-HCV coinfected patients Hepatitis coinfection - 2 April 2004
- London study finds sexual and intranasal transmission of HCV Hepatitis coinfection - 3 February 2004
- Hepatitis coinfection: incidence in Europe and response to transplant Conference reports - Hepatitis coinfection - EACS 9 Warsaw 2003 - 1 December 2003
- UK guidelines for treating coinfection with HIV and hepatitis B or C published online Hepatitis coinfection - 1 December 2003
- Kidney and liver transplantation in HIV-infected patients: case presentations and review Hepatitis coinfection - 1 December 2003
- Coinfected patients may require longer HCV treatment, irrespective of genotype Hepatitis coinfection - 1 November 2003
- Time on anti-HIV therapy is a protective factor for liver fibrosis in HIV-HCV coinfected patients Hepatitis coinfection - 1 October 2003
- HIV-HCV co-infected patients have poorer response to HCV therapy Hepatitis coinfection - 1 October 2003
- HIV coinfection, reinfection and superinfection Conference reports - Hepatitis coinfection - Resistance - Transmission and prevention - Intl Drug Resistance Workshop 12 Mexico 2003 - 1 September 2003
- Hepatitis A vaccine provides affordable protection in HIV-positive individuals Hepatitis coinfection - 1 July 2003
- PEG-interferon alfa-2b plus ribavirin for treatment of CHC patients who failed or relapsed following interferon-based therapy Hepatitis coinfection - 1 July 2003
- Pegylated interferon plus ribavirin improves fibrosis in non-responders to standard interferon therapy Hepatitis coinfection - 1 July 2003
- Coinfection: Hepatitis coverage from the Digestive Disease Week Conference Hepatitis coinfection - On the web - 1 July 2003
- Genotype, enzyme levels, and viral load are clues to hepatitis C virus outcomes Hepatitis coinfection - 1 June 2003
- Adherence and mental side effects during HCV treatment with interferon alfa and ribavirin in psychiatric risk groups Hepatitis coinfection - 1 June 2003
- Co-infection: liver transplantation in HIV-positive persons Hepatitis coinfection - On the web - 1 June 2003
- BHIVA HIV/hepatitis B and HIV/hepatitis C co-infection guidelines posted to web for consultation Hepatitis coinfection - 1 May 2003
- Index of biochemical markers could reduce need for biopsy by half in HIV/HCV co-infected patients Hepatitis coinfection - 1 May 2003
- HCV protects against abnormal blood lipids in HAART-treated HIV patients Hepatitis coinfection - 1 May 2003
- Low dose 200/100 IDV/RTV managed by TDM in substudy of co-infected patients Conference reports - Hepatitis coinfection - PK and drug interactions - CROI 10 (Retrovirus) 2003 - 1 April 2003
- 12-week response predicts which HIV-HCV coinfected patients will not benefit from continued pegylated interferon plus ribavirin Conference reports - Hepatitis coinfection - CROI 10 (Retrovirus) 2003 - 1 April 2003
- Pegylated interferon associated with eye disorders Conference reports - Hepatitis coinfection - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003
- Hepatitis C virus viraemia in HIV-positive individuals with negative HCV antibody tests Hepatitis coinfection - 1 March 2003